Derion Blackman, 50, collapsed and died in front of a Dollar General in Kissimmee in March after what his wife describes as a months‑long battle to get the antirejection drugs that kept his transplanted heart functioning. Earlier this year, the couple changed his primary coverage to avoid a sharp premium hike, and family members say a tangle of paperwork and billing errors left him without critical medication. His death has become a local warning about how even routine coverage changes can open up dangerous gaps in care.
Family says red tape blocked prescriptions
According to CBS News, by the time Blackman collapsed outside the Dollar General in March, the 50‑year‑old had been waiting roughly two months to regain access to some of the vital post‑transplant drugs he needed. The couple told reporters they had switched from a Federal Employees Health Benefits plan when their monthly premium was set to more than double to about $307, moving Blackman’s primary coverage to CHAMPVA instead. Smith says CHAMPVA initially showed his previous insurer as the primary payer, a mistake that took six weeks to fix and that delayed some prescriptions while providers and the plan traded paperwork.
How CHAMPVA works and why claims can stall
CHAMPVA, a Department of Veterans Affairs program for certain dependents and survivors, operates differently from most commercial insurance plans. Beneficiaries usually pay a small prescription deductible and a 25% cost‑share, with “The maximum out-of-pocket cost for your entire household under this plan is $3,000 each calendar year,” according to the Department of Veterans Affairs. In practice, that setup can mean patients pay out of pocket at pharmacies that do not accept CHAMPVA, then file for reimbursement later, which can slow access to medication.
The program has also grown rapidly. CHAMPVA recently reached about 1 million enrollees, which can complicate administration and provider familiarity with the benefit, according to VA News.
Policy context: higher deductibles and fragile transitions
Broader coverage shows Blackman’s situation is not an isolated one. With pandemic‑era premium subsidies ending and plan prices climbing, many patients have been pushed into lower‑cost options with narrower drug coverage. That raises the odds that prescriptions and prior authorizations will not carry over cleanly from one plan to another.
An analysis by KFF found that average Marketplace deductibles rose sharply in 2026, and experts warn that switching plans can quickly unravel months of approvals or carefully arranged pharmacy routines.
Survivor's plea and steps patients can take
Smith told WUSF she was furious with CHAMPVA and officials after her husband’s death, saying, “He didn't deserve to die like that.” Reporting and advocates highlight several practical moves patients can make when changing coverage: keep written records of prescriptions and prior authorizations, give the new insurer’s information to every treating clinician right away, and ask pharmacies and providers to re‑submit prescriptions or authorizations quickly so there is no gap in refills. Patient navigators and beneficiary services at the VA or local veterans offices can sometimes speed corrections, though families say the bureaucracy often moves slowly.
Local health advocates say Blackman’s death underscores how coverage choices, even those made to save money, can carry real medical risk when specialty drugs are involved. “The Department of Veterans Affairs declined to comment on the record about Blackman's case,” reporting shows, and family members are calling for stronger continuity protections and faster administrative fixes so other patients are not stranded between plans. For people facing a coverage change, experts cited in the reporting suggest contacting plan case managers early, keeping a paper list of medications and prior approvals, and asking pharmacies about advance or emergency fills while the paperwork gets sorted out.
